Amyris Biotechnologies Gets $41.75M
Emeryville-based Amyris Biotechnologies, a developer of renewable chemical and biodiesel processes, said Thursday that it has raised $41.75M in a Series C funding round. The round came from GrupoCornelioBrennand of Brazil and Naxos UK, along with Khosla Ventures, Kleiner Perkins Caufield & Byers, TPG Biotech and Votorantim Novos Negocios. The firm said the firm is anticipating additional closes in the round, whichi s targeted at $60M. That additional funding will bring the company's total raised to $165M.
posted on Thursday, October 1, 2009
Related companies:
Amyris Biotechnologies
Related stories:
> Amyris Biotechnologies Raises $70M
> Amyris Biotechnologies Gets $24.75M
> Amyris Raises $20M From Khosla
> Amyris Fuels Up With $83.7M
> Refuge Biotechnologies Picks Up $25M
silicontap.com Home